Tetrabuthylammonium

Tetrabuthylammonium

SCHEMBL1373677

Br.CCCC[N+](CCCC)(CCCC)CCCC

nearest known ligand 0.92

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ACHEADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3APH1AAPH1BCHRM2CHRM3EZH2GRIN2AHTR1AHTR1BHTR1DHTR1FHTR3ANCSTNP2RY12PSEN1PSEN2PSENENSIGMAR1SLC6A2SLC6A3SLC6A4

The experimentally established mechanism targets of Tetrabuthylammonium. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 12)

geneUniProtsupporting neighboursconfidence
▸ SLC22A1 O15245 4/20 0.92
▸ SLC22A2 O15244 1/20 0.79
▸ TSHR P16473 2/20 0.69
▸ ALDH1A1 P00352 1/20 0.69
▸ TP53 P04637 1/20 0.69
▸ CYP3A4 P08684 1/20 0.69
▸ ALOX15 P16050 1/20 0.69
▸ ALOX12 P18054 1/20 0.69
▸ SMN1; SMN2 Q16637 1/20 0.69
▸ HIF1A Q16665 1/20 0.69
▸ HSD17B10 Q99714 1/20 0.69
▸ DNM1 Q05193 6/20 0.61

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Tetrabuthylammonium SCHEMBL19856402 1.00 SLC22A1 (0.92) SLC22A1SLC22A2TSHRALDH1A1TP53
Tetrabuthylammonium SCHEMBL27702955 1.00 SLC22A1 (0.92) SLC22A1SLC22A2TSHRALDH1A1TP53
Tetrabuthylammonium SCHEMBL37663 1.00 SLC22A1 (0.92) SLC22A1SLC22A2TSHRALDH1A1TP53
Tetrabuthylammonium SCHEMBL8679645 0.96 SLC22A1 (0.86) SLC22A1SLC22A2TSHRALDH1A1TP53
Tetrabuthylammonium SCHEMBL21525926 0.96 SLC22A1 (0.86) SLC22A1SLC22A2TSHRALDH1A1TP53
Tetrabuthylammonium SCHEMBL25332097 0.96 SLC22A1 (0.86) SLC22A1SLC22A2TSHRALDH1A1TP53
Tetrabuthylammonium SCHEMBL11349437 0.96 SLC22A1 (0.86) SLC22A1SLC22A2TSHRALDH1A1TP53
Tetrabuthylammonium SCHEMBL28484893 0.96 SLC22A1 (0.86) SLC22A1SLC22A2TSHRALDH1A1TP53
Tetrabuthylammonium SCHEMBL4299822 0.96 SLC22A1 (0.86) SLC22A1SLC22A2TSHRALDH1A1TP53
Tetrabuthylammonium SCHEMBL29043619 0.96 SLC22A1 (0.86) SLC22A1SLC22A2TSHRALDH1A1TP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 91 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-102008898-B Method for preparing positive charge microfiltration membrane AMERICAN MEMBRANE NANTONG CO LTD 2013-06-05 — — CN claimed
CN-102008898-A Method for preparing positive charge microfiltration membrane AMERICAN MEMBRANE NANTONG CO LTD 2011-04-13 — — CN claimed
CN-1107833-A Process for preparing diaryl carbonates BAYER AG (DE) 1995-09-06 — — CN claimed
WO-2024015589-A1 PERSONAL CARE DEVICES AND COSMETIC COMPOSITIONS PATHAK HOLDINGS LLC (US) 2024-01-18 — — WO disclosed
CN-111423587-B Thermosetting silicon-containing compound, composition for forming silicon-containing film, and method for forming pattern 信越化学工业株式会社 2023-01-31 — — CN disclosed
US-20220118416-A1 CROSSLINKED MULTILAYERED MATERIAL COMPOSITIONS, METHODS FOR THEIR PREPARATION AND APPLICATIONS THEREOF PATHAK HOLDINGS LLC 2022-04-21 — — US disclosed
CN-107540670-B Preparation method of 1- (3-chloropyrazolo [1,5a ] -4,5,6, 7-tetrahydropyridine-2-yl) -5-methylamine pyrazole-4-carbonitrile 湖北相和精密化学有限公司 2021-08-13 — — CN disclosed
EP-2864840-B1 COATED PHOTOCONDUCTORS HEWLETT PACKARD DEVELOPMENT CO (US) 2018-10-03 — — EP disclosed
US-20180098542-A1 METHODS OF PEST CONTROL IN SOYBEAN SYNGENTA PARTICIPATIONS AG (CH) 2018-04-12 — — US disclosed
US-9933715-B2 Coated photoconductors HEWLETT-PACKARD DEVELOPMENT COMPANY, L.P. (US) 2018-04-03 — — US disclosed
CN-107674826-A A kind of liquid bacterial culture device 陕西众兴高科生物科技有限公司 2018-02-09 — — CN disclosed
CN-1054836-C Process for preparing diaryl carbonates BAYER AG (DE) 2000-07-26 — — CN disclosed
CN-1183771-A Process for preparing racemic and enantiomeric 1- (pyridyl) -2-cyclohexylethylamine BOEHRINGER INGELHEIM PHARMA (US) 1998-06-03 — — CN disclosed
CN-1128763-A Oxazoloquinolinone derivatives, their preparation and their therapeutic use SYNTHELABO (FR) 1996-08-14 — — CN disclosed
CN-1107833-A Process for preparing diaryl carbonates BAYER AG (DE) 1995-09-06 — — CN disclosed
US-4861787-A Nematicidal compositions CIBA-GEIGY CORPORATION (US) 1989-08-29 — — US disclosed
EP-0263066-A2 2-Mercapto-oxadiazole and -thiadiazole derivatives, process for their preparation and nematicides containing them CIBA-GEIGY AG (CH) 1988-04-06 — — EP disclosed
EP-0128465-B1 PROCESS FOR PRODUCING BROMINATED ACENAPHTHYLENE CONDENSATES TOSOH CORPORATION (JP) 1986-08-27 — — EP disclosed
US-4333809-A Cross-linkable polycarbonate elastomers, a process for their preparation and use for packaging medicines BAYER AKTIENGESELLSCHAFT (DE) 1982-06-08 — — US disclosed
US-4145484-A LITHIUM, BROMINE, TETRABUTYLAMMONIUM BROMIDE THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF THE NAVY (US) 1979-03-20 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180098542-A1 METHODS OF PEST CONTROL IN SOYBEAN BTF3, BRS3, CCNB3 SLC22A1 2452/4885SLC22A2 2414/4885TSHR 1010/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback